4Chung SK,Lee KW,Kang HI,et al.Design and synthesis of potential inhibitors of the ergosterol biosynthesis as antifungal agents[J].Bioorg Med Chem,2000,8(10):2 475-2 486.
5Abi-Said D,Anaissie E,Uzun O,et al.The epidemiology of hematogenous candidiasis caused by different Candida species[J].Clin Infect Dis,1997,24(6):1 122-1 128.
6Douglas LJ. Candida biofilms and their role in infection[J].Microbiology,2003,11(1):30-36.
7Kontoyiannis DP,Lewis RE. Antifungal drug resistance of pathogenic fungi[J].Lancet,2002,359(9312):1 135-1 144.
8Baumgartner C,Freydiere A,Gile Y. Direct identification and recognition of yeast species from clinical material by using albicans ID and chromagar Candida plates[J].J Clin Microbiol,1996,34(2):454-456.
9Fricker-Hidalgo H,Vandapel O,Duchesne MA,et al. Comparison of the new API Candida system to the ID 32 C system for the identification of clinically important yeast species[J].J Clin Microbiol,1996,34(7):1 846-1 848.
10Pfaller MA,Houston A,Coffman S. Application of chromagar Candida for rapid screening of clinical specimens for Candida albicans,Candida tropicalis,Candida krusei and Candida (Torulopsis) glabrata[J].J Clin Microbiol,1996,34(1):58-61.
